Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 24,106 shares at $14.11 ($340K) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Open-market sale of $340k KALV by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.11 | 12,053 | $170K | 50.0% |
| 2 | $14.11 | 12,053 | $170K | 50.0% |
| Total | $14.11 avg | 24,106 | $340K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |